The following data is part of a premarket notification filed by Dade Behring, Inc. with the FDA for Bcs System.
Device ID | K013114 |
510k Number | K013114 |
Device Name: | BCS SYSTEM |
Classification | System, Multipurpose For In Vitro Coagulation Studies |
Applicant | DADE BEHRING, INC. GLASGOW SITE P.O. BOX 6101 Newark, DE 19714 -6101 |
Contact | Rebecca S Ayash |
Correspondent | Rebecca S Ayash DADE BEHRING, INC. GLASGOW SITE P.O. BOX 6101 Newark, DE 19714 -6101 |
Product Code | JPA |
Subsequent Product Code | GGP |
Subsequent Product Code | GIR |
CFR Regulation Number | 864.5425 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2001-09-18 |
Decision Date | 2001-11-09 |
Summary: | summary |
Device Identifier | submissionNumber | Supplement |
---|---|---|
00842768007491 | K013114 | 000 |
00842768019654 | K013114 | 000 |
00842768019661 | K013114 | 000 |